Navigation Links
PixelOptics Closes $45 Million Financing
Date:4/7/2011

ROANOKE, Va., April 7, 2011 /PRNewswire/ -- PixelOptics ("Pixel"), the world's first electronic focusing eyeglass company, announced today the successful closing of a $45M financing lead by Safeguard Scientifics, Inc. (NYSE: SFE).  The financing is comprised of $35M equity investment and $10M venture debt.  Participating venture capital organizations include: Safeguard Scientifics, Delphi Ventures, The Carlyle Group, Longitude Capital, and Stark Investments.  Horizon Technology Finance (Nasdaq: HRZN) provided the venture debt funding.

PixelOptics' core product emPower!™ was recently launched on March 18th during the International Vision Expo East in New York City.  emPower! is the world's first and only electronic focusing eyeglasses: www.emPowerEyeWear.com.  Capable of being fabricated in all prescriptions, emPower! will be available in numerous high fashion styles, shapes, sizes and colors beginning this spring.  emPower! changes optical power focus faster than the blink of an eye without moving parts and without making a sound.  These high-tech eyeglasses are waterproof and shock resistant and have three modes of operation: manual on, manual off, and fully automatic.

Ron Blum, O.D., Pixel's President and CEO said, "We are extremely pleased to have successfully closed on this new capital.  We also feel very humbled and fortunate to have forged such a very strong and credible financial syndicate led by a quality company such as Safeguard Scientifics. This will now allow us to grow Pixel properly as well as provide the company with the needed capital to support an ambitious launch for emPower!.  We anticipate launching emPower! across North America and beginning a regional rollout in Europe within the next 12 months.  Following this, we expect to start selling emPower! in Asia within 24 months. "

Gary J. Kurtzman, M.D., Managing Director in the Life Sciences Group at Safeguard Scientifics stated, "The Pixel team has developed a disruptive technology with emPower! that will revolutionize the standard of care for eyeglass wearers, specifically those with presbyopia. Pixel aligns with Safeguard Scientifics' focus to partner with companies that have an innovative product or service, rapid path to commercialization and a strong management team. I have been wearing emPower! every day since we began our due diligence process and can't imagine going back to standard progressive lenses. I expect that millions of other eyeglass wearers around the world will agree." Dr. Kurtzman, along with Stephen T. Zarrilli, Senior Vice President and Chief Financial Officer at Safeguard Scientifics will be joining Pixel's board of directors.

Clay Musslewhite, Director of Marketing for Pixel further added, "emPower! has received unprecedented global media attention for an optical product from global media companies.  Within the last three months, emPower! has generated nearly 300 million impressions worldwide. Major media companies and publications, include The New York Times,  USA Today, Popular Science Magazine, CNN, CNBC, MSNBC, ABC, CBS, Fox Business, LIVE! with Regis and Kelly, Good Morning America, PC Magazine, Maximum Tech Magazine and foreign publications such as The London Times, NZZ Online (Switzerland), El Pais (Spain), The Telegraph (UK), MedIndia (India), The Eyes (Japan), fd.nl (The Netherlands), H KAOHMEPINH (Greece),  and La Tercera (Chile) have all highlighted emPower! within the last three months.  The public and media interest in emPower! is the strongest I have ever seen in the optical industry.  No other optical product (lenses and / or frames) has received such a high level of media attention and interest."

About PixelOptics:

Headquartered in Roanoke, Virginia, PixelOptics is committed to "transformational innovation" in the spectacle lens industry.  The company's focus is on improving and elevating the current standard of vision correction by inventing, developing and marketing a wide range of innovative new products based on dynamic focusing lenses, innovative lens design technologies, and composite optics. PixelOptics is dedicated to helping consumers see better and more comfortably, while at the same time helping the vision care industry to grow. For additional information on Pixel please visit: www.pixeloptics.com.  For additional information on emPower! electronic focusing eyeglasses please visit www.emPowerEyeWear.com

About Safeguard Scientifics:Founded in 1953 and based in Wayne, PA, Safeguard Scientifics, Inc. (NYSE: SFE) provides growth capital for entrepreneurial and innovative life sciences and technology companies. Safeguard targets life sciences companies in Molecular and Point-of-Care Diagnostics, Medical Devices, Regenerative Medicine, Specialty Pharmaceuticals and selected healthcare services, and technology companies in Internet / New Media, Financial Services IT, Healthcare IT and selected business services with capital requirements of up to $25 million. Safeguard participates in expansion financings, corporate spin-outs, management buyouts, recapitalizations, industry consolidations and early-stage financings. For more information, please visit our website at www.safeguard.com, our blog at blog.safeguard.com or you can follow us on Twitter @Safeguard and LinkedIn.

About Horizon Technology Finance Corporation:Horizon Technology Finance Corporation is a closed-end investment company that has elected to be treated as a business development company under the Investment Company Act of 1940. The Company provides secured loans to development-stage companies backed by established venture capital and private equity firms within the technology, life science, healthcare information and services, and clean-tech industries. The investment objective of Horizon Technology Finance is to maximize total risk-adjusted returns by generating current income from a portfolio of directly originated secured loans as well as capital appreciation from warrants to purchase the equity of portfolio companies. Headquartered in Farmington, CT, with a regional office in Walnut Creek, CA, the Company is externally managed by its investment advisor, Horizon Technology Finance Management LLC. To learn more, please visit www.horizontechnologyfinancecorp.com.Contact:Michael GoodwinMakovsky + Company212-508-9639mgoodwin@makovsky.com
'/>"/>

SOURCE PixelOptics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. AnaBios Corporation Closes Series A Financing
2. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
3. OncoSec Medical Closes $1.1M Financing
4. Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering
5. BridgePoint Medical Closes $9.1 Million Series C Financing
6. Palatin Technologies, Inc. Closes $23 Million Public Offering
7. Sonoma Orthopedic Products® Closes $22 Million Series D Financing
8. Rock Creek Pharmaceuticals Discloses Filing of Provisional Patent Application For Isolated Anatabine Isomer
9. Savient Closes Sale of $230 Million in Convertible Senior Notes
10. Inovio Pharmaceuticals Closes $24.3 Million Registered Offering
11. WebMD Closes Offering of 2.50% Convertible Notes Due 2018
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 24, 2016 According to a ... (Standard Pen Needles, Safety Pen Needles), Needle Length (4mm, ... Hormone), Mode of Purchase (Retail, Non-Retail) - Trends & ... studies the market for the forecast period of 2016 ... 2.81 Billion by 2021 from USD 1.65 Billion in ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, ... treatment. Dr. Cheng has extensive experience with all areas of orthodontics, including robotic ... osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It ...
(Date:6/24/2016)... ... 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join ... wage raise to $12 an hour by 2020 and then adjusting it yearly to increase ... of the minimum wage, assure the wage floor does not erode again, and make future ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative ... has initiated cultivation and processing operations at its production facility, and opened its ... Puradigm is the manufacturer of a complete system of proactive air and surface ...
Breaking Medicine News(10 mins):